Clinical Trials Sponsored by Gino gaddini

Total 175 results

gino gaddini

Terminated

Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study

Pre-diabetes | Diabetes Type 2

United States
Geno LLC

Completed

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. (PHiano)

Idiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension

United States
Geno LLC

Withdrawn

Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide (EAGLE)

Pulmonary Arterial Hypertension

United States
Geno LLC

Completed

Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide (PILOT)

Pulmonary Arterial Hypertension

United States
Associazione Ginco Ticino

Recruiting

Integration Between Learning, Body and Emotions (I-ACE) (I-ACE)

Quality of Life | Burnout, Professional | Dementia

Switzerland
Associazione Ginco Ticino

Completed

San Rocco Study: Implementation of the Non-pharmacological Therapies for People With Dementia Living in Nursing Home

Dementia | Nursing Home | Staff

Switzerland
Istituto Giannina Gaslini

Not yet recruiting

PCSP Implementation Study

Survivorship | Late Effect

Italy
Istituto Giannina Gaslini

Recruiting

Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome

Nephrotic Syndrome

Italy
Istituto Giannina Gaslini

Completed

Stress CMR in Pediatric Patients With Suspected Coronary Artery Disease

Coronary Disease

Italy
Istituto Giannina Gaslini

Completed

Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome

Nephrotic Syndrome

Italy
Istituto Giannina Gaslini

Not yet recruiting

Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children (CREATE)

Pericarditis
Istituto Giannina Gaslini

Completed

Rituximab for Idiopathic Nephrotic Syndrome

Idiopathic Nephrotic Syndrome

Italy
Istituto Giannina Gaslini

Terminated

Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome

Nephrotic Syndrome

Italy
Istituto Giannina Gaslini

Withdrawn

Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis

Systemic Lupus Erythematosus Nephritis

Italy
MINO Labs, LLC

Completed

Double-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers (CNXR-001D)

Photoaging

United States
Istituto Giannina Gaslini

Not yet recruiting

MONITORING NEUROMUSCULAR BLOCK IN PAEDIATRIC ANAESTHESIA (MOTOR)

Neuromuscular Blockade | Tracheal Intubation | Anesthesia,General
Istituto Giannina Gaslini

Recruiting

Music Therapy and High-risk Pregnancy

High Risk Pregnancy

Italy
Istituto Giannina Gaslini

Not yet recruiting

Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT (VS-TC)

Viral Infection After HSCT
Istituto Giannina Gaslini

Completed

Cryoanalgesia for Pain Management After Pectus Excavatum Repair (COPPER)

Pectus Excavatum

Italy
Istituto Giannina Gaslini

Unknown

Prediction of Outcome of Lupus Nephritis

Systemic Lupus Erythematosus

Italy
Istituto Giannina Gaslini

Completed

IL-2 for Multi Drug Resistant Nephrotic Syndrome

Nephrotic Syndrome

Italy
Istituto Giannina Gaslini

Completed

Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children (CLOVE)

Acute Leukemia

Italy
Nino Fijačko

Recruiting

Impact of Mobile Phone Application Use on Adult BLS (MOBI-CPR)

Stress | Knowledge, Attitudes, Practice | Mobile Phone Use | Out-Of-Hospital Cardiac Arrest

Slovenia
Istituto Giannina Gaslini
Eubrain

Recruiting

A Randomized Controlled Trial to Evaluate the Effect of White Noises and Parental Voices as Protectors Against Noise Damage in a Neonatal Intensive Care Unit

Premature Infant Disease

Italy
Sino-Swed Pharmaceutical Corporation

Completed

The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

Carcinoma Surgery | Parenteral Nutrition | Post-Operative Hospital Stay

China
Shenzhen Geno-Immune Medical Institute

Recruiting

CD19/79b Bi-specific CAR-T Cell Therapy

B Cell Malignancies

China
Shenzhen Geno-Immune Medical Institute

Recruiting

CD19/70 Bi-specific CAR-T Cell Therapy

B Cell Malignancies

China
Shenzhen Geno-Immune Medical Institute

Recruiting

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Acute Myeloid Leukemia | T-cell Acute Lymphoblastic Leukemia | T-cell Acute Lymphoblastic Lymphoma | NK Cell Lymphoma

China
Shenzhen Geno-Immune Medical Institute

Recruiting

CAR-T Immunotherapy Targeting CD19- ALL

B-cell Leukemia

China
Sino Medical Sciences Technology Inc.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) (RCT)

Coronary Artery Disease

China
Sino Medical Sciences Technology Inc.

Completed

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

Coronary Artery Disease | Stable Angina Pectoris | Unstable Angina Pectoris

China
Shenzhen Geno-Immune Medical Institute

Unknown

Genetically Modified T Cells Against Ovarian Cancer

Ovarian Cancer

China
Shenzhen Geno-Immune Medical Institute

Unknown

Intervention of Bladder Cancer by CAR-T

Bladder Cancer | Urothelial Carcinoma Bladder

China
Shenzhen Geno-Immune Medical Institute

Unknown

Lentiviral Gene Therapy for X-ALD

X-linked Adrenoleukodystrophy

China
Shenzhen Geno-Immune Medical Institute

Unknown

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Tuberculosis | CMV Infection | EBV Infection | Adenovirus Infection | Fungus Infection | Pathogen Infection | BKV Infection

China
Shenzhen Geno-Immune Medical Institute

Unknown

Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma

Multiple Myeloma

China
Shenzhen Geno-Immune Medical Institute

Unknown

Lentiviral FIX Gene Therapy

Hemophilia B
Shenzhen Geno-Immune Medical Institute

Unknown

Lentiviral FVIII Gene Therapy

Hemophilia A

China
Shenzhen Geno-Immune Medical Institute

Suspended

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

Ovarian Cancer

China
Sino Medical Sciences Technology Inc.

Completed

Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice (PANDA-III)

Coronary Artery Disease

China
Shenzhen Geno-Immune Medical Institute

Recruiting

GD2/CD56 Bi-specific CAR-T Cell Therapy

Malignant Disease

China
Shenzhen Geno-Immune Medical Institute

Recruiting

PSMA/CD70 Bi-specific CAR-T Cell Therapy

Cancer Disease

China
Shenzhen Geno-Immune Medical Institute

Recruiting

NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL

T-Cell Acute Lymphoblastic Leukemia

China
Shenzhen Geno-Immune Medical Institute

Recruiting

NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

B-Cell Acute Lymphoblastic Leukemia

China
Shenzhen Geno-Immune Medical Institute

Recruiting

Multiple CAR-T Cell Therapy Targeting AML

Acute Myeloid Leukemia

China
Shenzhen Geno-Immune Medical Institute

Unknown

Gene Transfer for ADA-SCID Using an Improved Lentiviral Vector (TYF-ADA)

Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)

China
Shenzhen Geno-Immune Medical Institute

Unknown

Lentiviral Gene Therapy for MLD

Metachromatic Leukodystrophy (MLD)

China
Shenzhen Geno-Immune Medical Institute

Unknown

Engineered Immune Effectors Against Cervical Cancer

Cervical Cancer

China
Shenzhen Geno-Immune Medical Institute

Unknown

Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells

Cancer

China
Shenzhen Geno-Immune Medical Institute

Unknown

Antigen-specific T Cells Against Lung Cancer

Lung Cancer

China

Clinical Trials Sponsored by Gino gaddini

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations